Candidate Gene Analyses of Skeletal Variation in Malocclusion

J Dent Res. 2015 Jul;94(7):913-20. doi: 10.1177/0022034515581643. Epub 2015 Apr 24.

Abstract

This study evaluated associations between craniofacial candidate genes and skeletal variation in patients with malocclusion. Lateral cephalometric radiographs of 269 untreated adults with skeletal classes I, II, and III malocclusion were digitized with 14 landmarks. Two-dimensional coordinates were analyzed using Procrustes fit and principal component (PC) analysis to generate continuous malocclusion phenotypes. Skeletal class classifications (I, II, or III) were used as a categorical phenotype. Individuals were genotyped for 198 single-nucleotide polymorphisms (SNPs) in 71 craniofacial genes and loci. Phenotype-genotype associations were tested via multivariate linear regression for continuous phenotypes and multinomial logistic regression for skeletal malocclusion class. PC analysis resulted in 4 principal components (PCs) explaining 69% of the total skeletal facial variation. PC1 explained 32.7% of the variation and depicted vertical discrepancies ranging from skeletal deep to open bites. PC1 was associated with a SNP near PAX5 (P = 0.01). PC2 explained 21.7% and captured horizontal maxillomandibular discrepancies. PC2 was associated with SNPs upstream of SNAI3 (P = 0.0002) and MYO1H (P = 0.006). PC3 explained 8.2% and captured variation in ramus height, body length, and anterior cranial base orientation. PC3 was associated with TWIST1 (P = 0.000076). Finally, PC4 explained 6.6% and detected variation in condylar inclination as well as symphysis projection. PC4 was associated with PAX7 (P = 0.007). Furthermore, skeletal class II risk increased relative to class I with the minor alleles of SNPs in FGFR2 (odds ratio [OR] = 2.1, P = 0.004) and declined with SNPs in EDN1 (OR = 0.5, P = 0.007). Conversely, skeletal class III risk increased versus class I with SNPs in FGFR2 (OR 2.2, P = 0.005) and COL1A1 (OR = 2.1, P = 0.008) and declined with SNPs in TBX5 (OR = 0.5, P = 0.014). PAX5, SNAI3, MYO1H, TWIST1, and PAX7 are associated with craniofacial skeletal variation among patients with malocclusion, while FGFR2, EDN1, TBX5, and COL1A1 are associated with type of skeletal malocclusion.

Keywords: angle class II; angle class III; association study; cephalometry; genetics; polymorphisms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anatomic Landmarks / pathology
  • Cephalometry / methods
  • Collagen Type I / genetics
  • Collagen Type I, alpha 1 Chain
  • DNA-Binding Proteins / genetics
  • Genetic Association Studies*
  • Genotype
  • Humans
  • Image Processing, Computer-Assisted / methods
  • Malocclusion, Angle Class I / genetics*
  • Malocclusion, Angle Class I / pathology
  • Malocclusion, Angle Class II / genetics*
  • Malocclusion, Angle Class II / pathology
  • Malocclusion, Angle Class III / genetics*
  • Malocclusion, Angle Class III / pathology
  • Mandible / pathology
  • Middle Aged
  • Myosin Type I
  • Nuclear Proteins / genetics
  • Open Bite / genetics
  • Overbite / genetics
  • PAX5 Transcription Factor / genetics
  • PAX7 Transcription Factor / genetics
  • Phenotype
  • Polymorphism, Single Nucleotide / genetics
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics
  • Snail Family Transcription Factors
  • T-Box Domain Proteins / genetics
  • Transcription Factors / genetics
  • Twist-Related Protein 1 / genetics
  • Young Adult
  • Zinc Fingers / genetics

Substances

  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • DNA-Binding Proteins
  • Nuclear Proteins
  • PAX5 Transcription Factor
  • PAX5 protein, human
  • PAX7 Transcription Factor
  • PAX7 protein, human
  • SNAI3 protein, human
  • Snail Family Transcription Factors
  • T-Box Domain Proteins
  • T-box transcription factor 5
  • TWIST1 protein, human
  • Transcription Factors
  • Twist-Related Protein 1
  • myosin 1H, human
  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2
  • Myosin Type I